-
1
-
2
-
3
-
4
-
5
-
6
-
7
Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers
Veröffentlicht in Cancer chemotherapy and pharmacology
VolltextArtikel -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
The risk of chronic kidney disease in a metabolically healthy obese population
Veröffentlicht in Kidney international
VolltextArtikel -
16
-
17
-
18
-
19
-
20
Prognostic significance of stromal GREM1 expression in colorectal cancer
Veröffentlicht in Human pathology
VolltextArtikel